Comparison of the effects of oxidative and inflammatory stresses on rat chondrocyte senescence

por Yagi, Misaki, Endo, Kentaro, Komori, Keiichiro, Sekiya, Ichiro
Publicado 2023

Clearance of senescent cells with ABT-263 improves biological functions of synovial mesenchymal stem cells from osteoarthritis patients

por Miura, Yugo, Endo, Kentaro, Komori, Keiichiro, Sekiya, Ichiro
Publicado 2022

Comparison of the yields and properties of dedifferentiated fat cells and mesenchymal stem cells derived from infrapatellar fat pads

por Fujii, Shunichi, Endo, Kentaro, Matsuta, Seiya, Komori, Keiichiro, Sekiya, Ichiro
Publicado 2022

TNFα promotes proliferation of human synovial MSCs while maintaining chondrogenic potential

por Shioda, Mikio, Muneta, Takeshi, Tsuji, Kunikazu, Mizuno, Mitsuru, Komori, Keiichiro, Koga, Hideyuki, Sekiya, Ichiro
Publicado 2017

Platelet-derived growth factor (PDGF)-AA/AB in human serum are potential indicators of the proliferative capacity of human synovial mesenchymal stem cells

por Mizuno, Mitsuru, Katano, Hisako, Otabe, Koji, Komori, Keiichiro, Matsumoto, Yukie, Fujii, Shizuka, Ozeki, Nobutake, Tsuji, Kunikazu, Koga, Hideyuki, Muneta, Takeshi, Matsuyama, Akifumi, Sekiya, Ichiro
Publicado 2015

Complete human serum maintains viability and chondrogenic potential of human synovial stem cells: suitable conditions for transplantation

por Mizuno, Mitsuru, Katano, Hisako, Otabe, Koji, Komori, Keiichiro, Kohno, Yuji, Fujii, Shizuka, Ozeki, Nobutake, Horie, Masafumi, Tsuji, Kunikazu, Koga, Hideyuki, Muneta, Takeshi, Sekiya, Ichiro
Publicado 2017

Petaloid recombinant peptide enhances in vitro cartilage formation by synovial mesenchymal stem cells

por Naritomi, Mana, Mizuno, Mitsuru, Katano, Hisako, Ozeki, Nobutake, Otabe, Koji, Komori, Keiichiro, Fujii, Shizuka, Ichinose, Shizuko, Tsuji, Kunikazu, Koga, Hideyuki, Muneta, Takeshi, Sekiya, Ichiro
Publicado 2018

Short cytoplasmic isoform of IL1R1/CD121a mediates IL1β induced proliferation of synovium-derived mesenchymal stem/stromal cells through ERK1/2 pathway

por Tang, Guo, Asou, Yoshinori, Matsumura, Etsuko, Nakagawa, Yusuke, Miyatake, Kazumasa, Katagiri, Hiroki, Nakamura, Tomomasa, Koga, Hideyuki, Komori, Keiichiro, Sekiya, Ichiro, Ezura, Yoich, Tsuji, Kunikazu
Publicado 2022

CD34(+)THY1(+) synovial fibroblast subset in arthritic joints has high osteoblastic and chondrogenic potentials in vitro

por Noda, Seiji, Hosoya, Tadashi, Komiya, Yoji, Tagawa, Yasuhiro, Endo, Kentaro, Komori, Keiichiro, Koga, Hideyuki, Takahara, Yasuhiro, Sugimoto, Kazutaka, Sekiya, Ichiro, Saito, Tetsuya, Mizoguchi, Fumitaka, Yasuda, Shinsuke
Publicado 2022

Correction: CD34(+)THY1(+) synovial fibroblast subset in arthritic joints has high osteoblastic and chondrogenic potentials in vitro

por Noda, Seiji, Hosoya, Tadashi, Komiya, Yoji, Tagawa, Yasuhiro, Endo, Kentaro, Komori, Keiichiro, Koga, Hideyuki, Takahara, Yasuhiro, Sugimoto, Kazutaka, Sekiya, Ichiro, Saito, Tetsuya, Mizoguchi, Fumitaka, Yasuda, Shinsuke
Publicado 2022

Specific markers and properties of synovial mesenchymal stem cells in the surface, stromal, and perivascular regions

por Mizuno, Mitsuru, Katano, Hisako, Mabuchi, Yo, Ogata, Yusuke, Ichinose, Shizuko, Fujii, Shizuka, Otabe, Koji, Komori, Keiichiro, Ozeki, Nobutake, Koga, Hideyuki, Tsuji, Kunikazu, Akazawa, Chihiro, Muneta, Takeshi, Sekiya, Ichiro
Publicado 2018

Yields and chondrogenic potential of primary synovial mesenchymal stem cells are comparable between rheumatoid arthritis and osteoarthritis patients

por Kohno, Yuji, Mizuno, Mitsuru, Ozeki, Nobutake, Katano, Hisako, Komori, Keiichiro, Fujii, Shizuka, Otabe, Koji, Horie, Masafumi, Koga, Hideyuki, Tsuji, Kunikazu, Matsumoto, Mikio, Kaneko, Haruka, Takazawa, Yuji, Muneta, Takeshi, Sekiya, Ichiro
Publicado 2017